RESUMO
Familial hemiplegic migraine type 1 (FHM1) is a rare migraine subtype. Whereas transgenic knock-in mice with the human pathogenic FHM1 R192Q missense mutation in the Cacna1a gene reveal overall neuronal hyperexcitability, the effects on the trigeminovascular system and calcitonin gene-related peptide (CGRP) receptor are largely unknown. This gains relevance as blockade of CGRP and its receptor are therapeutic targets under development. Hence, we set out to test these effects in FHM1 mice. We characterized the trigeminovascular system of wild-type and FHM1 mice through: (i) in vivo capsaicin- and CGRP-induced dural vasodilation in a closed-cranial window; (ii) ex vivo KCl-induced CGRP release from isolated dura mater, trigeminal ganglion and trigeminal nucleus caudalis; and (iii) peripheral vascular function in vitro . In mutant mice, dural vasodilatory responses were significantly decreased compared to controls. The ex vivo release of CGRP was not different in the components of the trigeminovascular system between genotypes; however, sumatriptan diminished the release in the trigeminal ganglion, trigeminal nucleus caudalis and dura mater but only in wild-type mice. Peripheral vascular function was similar between genotypes. These data suggest that the R192Q mutation might be associated with trigeminovascular CGRP receptor desensitization. Novel antimigraine drugs should be able to revert this complex phenomenon.
Assuntos
Peptídeo Relacionado com Gene de Calcitonina/genética , Canais de Cálcio Tipo N/genética , Ataxia Cerebelar/genética , Transtornos de Enxaqueca/genética , Mutação de Sentido Incorreto , Gânglio Trigeminal/química , Animais , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Técnicas de Introdução de Genes , Humanos , Camundongos , Doenças Vasculares Periféricas , VasodilataçãoRESUMO
Stromal cells/telocytes (SCs/TCs) were recently described in the human adult trigeminal ganglion (TG). As some markers are equally expressed in SCs/TCs and endothelial cells, we hypothesized that a subset of the TG SCs/TCs is in fact represented by endothelial progenitor cells of a myelomonocytic origin. This study aimed to evaluate whether the interstitial cells of the human adult TG correlate with the myelomonocytic lineage. We used primary antibodies for c-erbB2/HER-2, CD31, nestin, CD10, CD117/c-kit, von Willebrand factor (vWF), CD34, Stro-1, CD146, α-smooth muscle actin (α-SMA), CD68, VEGFR-2 and cytokeratin 7 (CK7). The TG pial mesothelium and subpial vascular microstroma expressed c-erbB2/HER-2, CK7 and VEGFR-2. SCs/TCs neighbouring the neuronoglial units (NGUs) also expressed HER-2, which suggests a pial origin. These cells were also positive for CD10, CD31, CD34, CD68 and nestin. Endothelial cells expressed CD10, CD31, CD34, CD146, nestin and vWF. We also found vasculogenic networks with spindle-shaped and stellate endothelial progenitors expressing CD10, CD31, CD34, CD68, CD146 and VEGFR-2. Isolated mesenchymal stromal cells expressed Stro-1, CD146, CK7, c-kit and nestin. Pericytes expressed α-SMA and CD146. Using transmission electron microscopy (TEM), we found endothelial-specific Weibel-Palade bodies in spindle-shaped stromal progenitors. Our study supports the hypothesis that an intrinsic vasculogenic niche potentially involved in microvascular maintenance and repair might be present in the human adult trigeminal ganglion and that it might be supplied by either the pial mesothelium or the bone marrow niche.
Assuntos
Células Endoteliais/ultraestrutura , Células-Tronco/ultraestrutura , Células Estromais/ultraestrutura , Telócitos/ultraestrutura , Gânglio Trigeminal/ultraestrutura , Biomarcadores/análise , Células Endoteliais/química , Humanos , Imuno-Histoquímica , Microscopia Eletrônica de Transmissão , Receptor ErbB-2/química , Células-Tronco/química , Células Estromais/química , Telócitos/química , Gânglio Trigeminal/anatomia & histologia , Gânglio Trigeminal/química , Nervo Trigêmeo/química , Nervo Trigêmeo/ultraestrutura , Corpos de Weibel-Palade/química , Corpos de Weibel-Palade/ultraestruturaRESUMO
Pituitary adenylate cyclase-activating peptide (PACAP) is a neuropeptide implicated in a wide range of functions, such as nociception and in primary headaches. Regarding its localization, PACAP has been observed in the sensory trigeminal ganglion (TG), in the parasympathetic sphenopalatine (SPG) and otic ganglia (OTG), and in the brainstem trigeminocervical complex. Immunohistochemistry has shown PACAP-38 in numerous cell bodies of SPG/OTG, co-stored with vasoactive intestinal peptide (VIP), nitric oxide synthase (NOS) and, to a minor degree, with choline acetyltransferase. PACAP has in addition been found in a subpopulation of calcitonin gene-related peptide (CGRP)-immunoreactive cells in the trigeminal system. The PACAP/VIP receptors (PAC1, VPAC1, and VPAC2) are present in sensory neurons and in vascular smooth muscle related to the trigeminovascular system. It is postulated that PACAP is involved in nociception. In support, abolishment of PACAP synthesis or reception leads to diminished pain responses, whereas systemic PACAP-38 infusion triggers pain behavior in animals and delayed migraine-like attacks in migraine patients without marked vasodilatory effects. In addition, increased plasma levels have been documented in acute migraine attacks and in cluster headache, in accordance with findings in experimental models of trigeminal activation. This suggest that the activation of the trigeminal system may result in elevated venous levels of PACAP, a change that can be reduced when headache is treated. The data presented in this review indicate that PACAP and its receptors may be promising targets for migraine therapeutics.
Assuntos
Transtornos da Cefaleia Primários/metabolismo , Polipeptídeo Hipofisário Ativador de Adenilato Ciclase/metabolismo , Animais , Gânglios Parassimpáticos/química , Gânglios Parassimpáticos/metabolismo , Transtornos da Cefaleia Primários/diagnóstico , Transtornos da Cefaleia Primários/terapia , Humanos , Neurônios Aferentes/química , Neurônios Aferentes/metabolismo , Receptores de Polipeptídeo Hipofisário Ativador de Adenilato Ciclase/análise , Receptores de Polipeptídeo Hipofisário Ativador de Adenilato Ciclase/metabolismo , Receptores Tipo I de Polipeptídeo Intestinal Vasoativo/análise , Receptores Tipo I de Polipeptídeo Intestinal Vasoativo/metabolismo , Gânglio Trigeminal/química , Gânglio Trigeminal/metabolismo , Peptídeo Intestinal Vasoativo/análise , Peptídeo Intestinal Vasoativo/metabolismoRESUMO
Prostaglandin E2 (PGE2) is a key proinflammatory mediator that contributes to inflammatory hyperalgesia. Voltage-gated sodium channel 1.7 (Nav1.7) plays an important role in inflammatory pain. However, the modulation of Nav1.7 in inflammatory pain remains poorly understood. We hypothesized that PGE2 might regulate Nav1.7 expression in inflammatory pain. We here showed that treatment of rat trigeminal ganglion (TG) explants with PGE2 significantly upregulated the mRNA and protein expressions of Nav1.7 through PGE2 receptor EP2. This finding was confirmed by studies on EP2-selective antagonist PF-04418948. We also demonstrated that Nav1.7 and COX-2 expressions, as well as PGE2 levels, were upregulated in the TG after induction of rats' temporomandibular joint (TMJ) inflammation. Correspondingly, hyperalgesia, as indicated by head withdrawal threshold, was observed. Moreover, TMJ inflammation-induced upregulation of Nav1.7 expression and PGE2 levels in the TG could be reversed by COX-2-selective inhibitor meloxicam given by oral gavage, and meanwhile, the hyperalgesia of inflamed TMJ was also mitigated. So we concluded that PGE2 upregulated trigeminal ganglionic Nav1.7 expression to contribute to TMJ inflammatory pain in rats. Our finding suggests that PGE2 was an important regulator of Nav1.7 in TMJ inflammatory pain, which may help increase understanding on the hyperalgesia of peripheral inflammation and develop a new strategy to address inflammatory pain.
Assuntos
Dinoprostona/farmacologia , Canal de Sódio Disparado por Voltagem NAV1.7/metabolismo , Canais de Sódio/metabolismo , Articulação Temporomandibular/patologia , Gânglio Trigeminal/química , Animais , Dinoprostona/fisiologia , Inflamação , Canal de Sódio Disparado por Voltagem NAV1.7/genética , Dor , RNA Mensageiro/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Regulação para CimaRESUMO
ABSTRACT Objectives The aim of this study was to explore the effect of capsaicin on expression patterns of calcitonin gene-related peptide (CGRP) in the trigeminal ganglion (TG) and trigeminal subnucleus caudalis (Vc) following experimental tooth movement. Material and Methods Male Sprague-Dawley rats were used in this study and divided into small-dose capsaicin+force group, large-dose capsaicin+force group, saline+force group, and no force group. Closed coil springs were used to mimic orthodontic forces in all groups except for the no force group, in which springs were inactivated. Capsaicin and saline were injected into periodontal tissues. Rats were euthanized at 0 h, 12 h, 1 d, 3 d, 5 d, and 7 d following experimental tooth movement. Then, TG and Vc were obtained for immunohistochemical staining and western blotting against CGRP. Results Immunohistochemical results indicated that CGRP positive neurons were located in the TG, and CGRP immunoreactive fibers were distributed in the Vc. Immunohistochemical semiquantitative analysis and western blotting analysis demonstrated that CGRP expression levels both in TG and Vc were elevated at 12 h, 1 d, 3 d, 5 d, and 7 d in the saline + force group. However, both small-dose and large-dose capsaicin could decrease CGRP expression in TG and Vc at 1 d and 3 d following experimental tooth movement, as compared with the saline + force group. Conclusions These results suggest that capsaicin could regulate CGRP expression in TG and Vc following experimental tooth movement in rats.
Assuntos
Animais , Masculino , Técnicas de Movimentação Dentária/métodos , Núcleo Inferior Caudal do Nervo Trigêmeo/efeitos dos fármacos , Capsaicina/farmacologia , Peptídeo Relacionado com Gene de Calcitonina/efeitos dos fármacos , Gânglio Trigeminal/efeitos dos fármacos , Fármacos do Sistema Sensorial/farmacologia , Valores de Referência , Fatores de Tempo , Núcleo Inferior Caudal do Nervo Trigêmeo/química , Dor Facial , Imuno-Histoquímica , Cloreto de Sódio , Distribuição Aleatória , Peptídeo Relacionado com Gene de Calcitonina/análise , Western Blotting , Gânglio Trigeminal/química , Reprodutibilidade dos Testes , Ratos Sprague-DawleyRESUMO
This work presents new data concerning the immunohistochemical occurrence of the transient receptor potential vanilloid type-1 (TRPV1) receptor in the human trigeminal ganglion (TG) and spinal nucleus of subjects at different ontogenetic stages, from prenatal life to postnatal old age. Comparisons are made with the sensory neuropeptides calcitonin gene-related peptide (CGRP) and substance P (SP). TRPV1-like immunoreactive (LI) material was detected by western blot in homogenates of TG and medulla oblongata of subjects at prenatal and adult stages of life. Immunohistochemistry showed that expression of the TRPV1 receptor is mostly restricted to the small- and medium-sized TG neurons and to the caudal subdivision of the spinal trigeminal nucleus (Sp5C). The extent of the TRPV1-LI TG neuronal subpopulation was greater in subjects at early perinatal age than at late perinatal age and in postnatal life. Centrally, the TRPV1 receptor localized to fibre tracts and punctate elements, which were mainly distributed in the spinal tract, lamina I and inner lamina II of the Sp5C, whereas stained cells were rare. The TRPV1 receptor colocalized partially with CGRP and SP in the TG, and was incompletely codistributed with both neuropeptides in the spinal tract and in the superficial laminae of the Sp5C. Substantial differences were noted with respect to the distribution of the TRPV1-LI structures described in the rat Sp5C and with respect to the temporal expression of the receptor during the development of the rat spinal dorsal horn. The distinctive localization of TRPV1-LI material supports the concept of the involvement of TRPV1 receptor in the functional activity of the protopathic compartment of the human trigeminal sensory system, i.e. the processing and neurotransmission of thermal and pain stimuli.
Assuntos
Peptídeo Relacionado com Gene de Calcitonina/análise , Substância P/análise , Canais de Cátion TRPV/análise , Gânglio Trigeminal/química , Núcleo Espinal do Trigêmeo/química , Adulto , Idoso de 80 Anos ou mais , Sequência de Aminoácidos , Animais , Peptídeo Relacionado com Gene de Calcitonina/genética , Criança , Feminino , Feto , Humanos , Masculino , Pessoa de Meia-Idade , Neuropeptídeos/análise , Neuropeptídeos/genética , Gravidez , Ratos , Substância P/genética , Canais de Cátion TRPV/genéticaRESUMO
AIMS: To test the hypothesis that prolonged jaw opening, as can occur during routine dental procedures, increases nociceptive sensitivity of the masseter muscle and increases cytokine expression. METHODS: Sprague-Dawley rats were used to investigate behavioral and cellular changes in response to prolonged jaw opening. A surgical retractor was placed around the maxillary and mandibular incisors, and the jaw was held at near maximal opening for 20 minutes. Head-withdrawal responses to mechanical stimuli applied to the facial skin overlying the left and right masseter muscles were determined following jaw opening. Cytokine levels in the upper cervical spinal cord containing the caudal part of the spinal trigeminal nucleus were evaluated using protein antibody microarrays (n = 3). Statistical analysis was performed using a nonparametric Mann-Whitney U test. RESULTS: Prolonged jaw opening significantly increased nocifensive head withdrawal to mechanical stimuli at 2 hours, and days 3 and 7 postinduction (P < .05). The increase in nociceptive response resolved after 14 days. Sustained jaw opening also stimulated differential cytokine expression in the trigeminal ganglion and upper cervical spinal cord that persisted 14 days postprocedure (P < .05). CONCLUSION: These findings provide evidence that near maximal jaw opening can lead to activation and prolonged sensitization of trigeminal neurons that results in nociceptive behavior evoked by stimulation of the masseter muscle, a physiologic event often associated with temporomandibular disorders (TMD). Results from this study may provide a plausible explanation for why some patients develop TMD after routine dental procedures that involve prolonged jaw opening.
Assuntos
Citocinas/análise , Músculo Masseter/fisiopatologia , Nociceptividade/fisiologia , Amplitude de Movimento Articular/fisiologia , Articulação Temporomandibular/fisiopatologia , Animais , Quimiocina CXCL1/análise , Fator Neurotrófico Ciliar/análise , Movimentos da Cabeça/fisiologia , Interleucinas/análise , Masculino , Mandíbula/fisiopatologia , Músculo Masseter/inervação , Nociceptores/química , Nociceptores/fisiologia , Estimulação Física , Ratos , Ratos Sprague-Dawley , Medula Espinal/química , Medula Espinal/fisiopatologia , Fatores de Tempo , Tato/fisiologia , Gânglio Trigeminal/química , Gânglio Trigeminal/fisiopatologia , Núcleo Espinal do Trigêmeo/química , Núcleo Espinal do Trigêmeo/fisiopatologia , Fator de Necrose Tumoral alfa/análiseRESUMO
Objectives: The aim of this study was to explore the effect of capsaicin on expression patterns of calcitonin gene-related peptide (CGRP) in the trigeminal ganglion (TG) and trigeminal subnucleus caudalis (Vc) following experimental tooth movement. Material and Methods: Male Sprague-Dawley rats were used in this study and divided into small-dose capsaicin+force group, large-dose capsaicin+force group, saline+force group, and no force group. Closed coil springs were used to mimic orthodontic forces in all groups except for the no force group, in which springs were inactivated. Capsaicin and saline were injected into periodontal tissues. Rats were euthanized at 0 h, 12 h, 1 d, 3 d, 5 d, and 7 d following experimental tooth movement. Then, TG and Vc were obtained for immunohistochemical staining and western blotting against CGRP. Results: Immunohistochemical results indicated that CGRP positive neurons were located in the TG, and CGRP immunoreactive fibers were distributed in the Vc. Immunohistochemical semiquantitative analysis and western blotting analysis demonstrated that CGRP expression levels both in TG and Vc were elevated at 12 h, 1 d, 3 d, 5 d, and 7 d in the saline + force group. However, both small-dose and large-dose capsaicin could decrease CGRP expression in TG and Vc at 1 d and 3 d following experimental tooth movement, as compared with the saline + force group. Conclusions: These results suggest that capsaicin could regulate CGRP expression in TG and Vc following experimental tooth movement in rats.
Assuntos
Peptídeo Relacionado com Gene de Calcitonina/efeitos dos fármacos , Capsaicina/farmacologia , Fármacos do Sistema Sensorial/farmacologia , Técnicas de Movimentação Dentária/métodos , Núcleo Inferior Caudal do Nervo Trigêmeo/efeitos dos fármacos , Gânglio Trigeminal/efeitos dos fármacos , Animais , Western Blotting , Peptídeo Relacionado com Gene de Calcitonina/análise , Dor Facial , Imuno-Histoquímica , Masculino , Distribuição Aleatória , Ratos Sprague-Dawley , Valores de Referência , Reprodutibilidade dos Testes , Cloreto de Sódio , Fatores de Tempo , Núcleo Inferior Caudal do Nervo Trigêmeo/química , Gânglio Trigeminal/químicaRESUMO
AIMS: Our studies investigated the location of oxytocin receptors in the peripheral trigeminal sensory system and determined their role in trigeminal pain. METHODS: Oxytocin receptor expression and co-localization with calcitonin gene-related peptide was investigated in rat trigeminal ganglion using immunohistochemistry. Enzyme-linked immunosorbent assay was used to determine the effects of facial electrocutaneous stimulation and adjuvant-induced inflammation of the temporomandibular joint on oxytocin receptor expression in the trigeminal ganglion. Finally, the effects of oxytocin on capsaicin-induced calcitonin gene-related peptide release from dural nociceptors were investigated using isolated rat dura mater. RESULTS: Oxytocin receptor immunoreactivity was present in rat trigeminal neurons. The vast majority of oxytocin receptor immunoreactive neurons co-expressed calcitonin gene-related peptide. Both electrocutaneous stimulation and adjuvant-induced inflammation led to a rapid upregulation of oxytocin receptor protein expression in trigeminal ganglion neurons. Oxytocin significantly and dose-dependently decreased capsaicin-induced calcitonin gene-related peptide release from dural nociceptors. CONCLUSION: Oxytocin receptor expression in calcitonin gene-related peptide containing trigeminal ganglion neurons, and the blockade of calcitonin gene-related peptide release from trigeminal dural afferents suggests that activation of these receptors may provide therapeutic benefit in patients with migraine and other primary headache disorders.
Assuntos
Transtornos da Cefaleia/metabolismo , Nociceptores/metabolismo , Receptores de Ocitocina/biossíntese , Gânglio Trigeminal/metabolismo , Animais , Peptídeo Relacionado com Gene de Calcitonina/análise , Peptídeo Relacionado com Gene de Calcitonina/biossíntese , Peptídeo Relacionado com Gene de Calcitonina/genética , Regulação da Expressão Gênica , Transtornos da Cefaleia/genética , Masculino , Ratos , Ratos Sprague-Dawley , Receptores de Ocitocina/análise , Receptores de Ocitocina/genética , Resultado do Tratamento , Gânglio Trigeminal/químicaRESUMO
AIMS: To determine whether behavioral, anatomical, and physiologic endpoints widely used to infer the presence of pain in rodent models of temporomandibular disorders (TMD) were applicable to the rabbit model of TMD associated with altered joint loading. METHODS: Unilateral molar dental splints were used to alter temporomandibular joint (TMJ) loading. Changes in nociceptive threshold were assessed with a mechanical probing of the TMJ region on nine splinted and three control rabbits. Fos-like immunoreacitivty in the trigeminal subnucleus caudalis was assessed with standard immunohistochemical techniques from three splinted and six control animals. Retrogradely labeled TMJ afferents were studied with patch-clamp electrophysiologic techniques from three splinted and three control animals. Remodeling of TMJ condyles was assessed by histologic investigations of three splinted and three control animals. A Student t test or a Mann-Whitney U test was used with significance set at P < .05 to compare splinted to control samples. RESULTS: While variable, there was an increase in mechanical sensitivity in splinted rabbits relative to controls. The increase in Fos+ cells in splinted rabbits was also significant relative to naïve controls (86 ± 8 vs 64 ± 15 cells/section, P < .05). The rheobase (364 ± 80 pA) and action potential threshold (-31.2 ± 2.0 mV) were higher in TMJ afferents from splinted rabbits compared to controls (99 ± 22 pA and -38.0 ± 2.0 mV, P < .05). There was significant remodeling in the condylar fibrocartilage layers as manifested by a change in glycosaminoglycan distribution and a loss of defined cell layers. CONCLUSION: Behavioral and anatomical results were consistent with an increase in nociceptive signaling in concert with condylar remodeling driven by altered TMJ loading. Changes in excitability and action potential waveform were consistent with possible compensatory changes of TMJ afferents for an overall increase in afferent drive associated with joint degeneration. These compensatory changes may reflect pain-adaption processes that many patients with TMJ disorders experience.
Assuntos
Dor Facial/etiologia , Transtornos da Articulação Temporomandibular/etiologia , Potenciais de Ação/fisiologia , Animais , Reabsorção Óssea/patologia , Tronco Encefálico/química , Tronco Encefálico/patologia , Cartilagem Articular/química , Cartilagem Articular/patologia , Modelos Animais de Doenças , Dor Facial/patologia , Dor Facial/fisiopatologia , Feminino , Glicosaminoglicanos/análise , Má Oclusão/complicações , Côndilo Mandibular/química , Côndilo Mandibular/patologia , Neurônios Aferentes/fisiologia , Nociceptividade/fisiologia , Limiar da Dor/fisiologia , Técnicas de Patch-Clamp , Proteínas Proto-Oncogênicas c-fos/análise , Coelhos , Contenções , Estresse Mecânico , Articulação Temporomandibular/inervação , Transtornos da Articulação Temporomandibular/patologia , Transtornos da Articulação Temporomandibular/fisiopatologia , Núcleo Inferior Caudal do Nervo Trigêmeo/química , Núcleo Inferior Caudal do Nervo Trigêmeo/patologia , Gânglio Trigeminal/química , Gânglio Trigeminal/patologiaRESUMO
To investigate whether transient receptor potential vanilloid type 1 (TRPV1) is involved in pain induced by experimental tooth movement, experiments were performed in male Sprague-Dawley rats weighing 200-250 g. Directed face-grooming behavior was used to evaluate nocifensive behavior in rats during experimental tooth movement. The distribution of TRPV1 in the trigeminal ganglion (TG) was evaluated by immunohistochemistry, and its expression was detected by western blotting at several time points following the application of various magnitudes of force during tooth movement. Immunohistochemical analysis revealed that TRPV1 was expressed in TG, and its expression was increased after experimental tooth movement. Western blot results also showed that experimental tooth movement led to a statistically significant increase in expression of TRPV1 protein in TG. Meanwhile, the time spent on directed face-grooming peaked on day 1 and thereafter showed a gradual decrease. In addition, both the change in TRPV1 expression in the TG and directed face-grooming behavior were modulated in a force-dependent manner and in concert with initial orthodontic pain responses. Our results reveal that TRPV1 expression is modulated by experimental tooth movement and is involved in tooth-movement pain.
Assuntos
Dor Facial/metabolismo , Canais de Cátion TRPV/análise , Técnicas de Movimentação Dentária , Gânglio Trigeminal/química , Acrilamidas/farmacologia , Animais , Fenômenos Biomecânicos , Compostos Bicíclicos Heterocíclicos com Pontes/farmacologia , Peptídeo Relacionado com Gene de Calcitonina/análise , Imunofluorescência , Asseio Animal/efeitos dos fármacos , Asseio Animal/fisiologia , Masculino , Neurônios/química , Dor Nociceptiva/metabolismo , Fios Ortodônticos , Ratos , Ratos Sprague-Dawley , Estresse Mecânico , Canais de Cátion TRPV/antagonistas & inibidores , Fatores de Tempo , Técnicas de Movimentação Dentária/instrumentaçãoRESUMO
Orofacial cold hyperalgesia is known to cause severe persistent pain in the face following trigeminal nerve injury or inflammation, and transient receptor potential (TRP) vanilloid 1 (TRPV1) and TRP ankylin 1 (TRPA1) are thought to be involved in cold hyperalgesia. However, how these two receptors are involved in cold hyperalgesia is not fully understood. To clarify the mechanisms underlying facial cold hyperalgesia, nocifensive behaviors to cold stimulation, the expression of TRPV1 and TRPA1 in trigeminal ganglion (TG) neurons, and TG neuronal excitability to cold stimulation following facial capsaicin injection were examined in rats. The head-withdrawal reflex threshold (HWRT) to cold stimulation of the lateral facial skin was significantly decreased following facial capsaicin injection. This reduction of HWRT was significantly recovered following local injection of TRPV1 antagonist as well as TRPA1 antagonist. Approximately 30% of TG neurons innervating the lateral facial skin expressed both TRPV1 and TRPA1, and about 64% of TRPA1-positive neurons also expressed TRPV1. The TG neuronal excitability to noxious cold stimulation was significantly increased following facial capsaicin injection and this increase was recovered by pretreatment with TRPA1 antagonist. These findings suggest that TRPA1 sensitization via TRPV1 signaling in TG neurons is involved in cold hyperalgesia following facial skin capsaicin injection.
Assuntos
Capsaicina/efeitos adversos , Temperatura Baixa/efeitos adversos , Dor Facial/etiologia , Hiperalgesia/etiologia , Fármacos do Sistema Sensorial/efeitos adversos , Canais de Cátion TRPC/fisiologia , Acetanilidas/farmacologia , Anilidas/farmacologia , Animais , Comportamento Animal , Capsaicina/farmacologia , Cinamatos/farmacologia , Eletromiografia/instrumentação , Face , Temperatura Alta/efeitos adversos , Injeções Intradérmicas , Masculino , Condução Nervosa/efeitos dos fármacos , Condução Nervosa/fisiologia , Neurônios/química , Neurônios/efeitos dos fármacos , Estimulação Física , Purinas/farmacologia , Ratos , Ratos Sprague-Dawley , Reflexo/efeitos dos fármacos , Reflexo/fisiologia , Fármacos do Sistema Sensorial/farmacologia , Transmissão Sináptica/efeitos dos fármacos , Transmissão Sináptica/fisiologia , Canal de Cátion TRPA1 , Canais de Cátion TRPC/análise , Canais de Cátion TRPC/antagonistas & inibidores , Canais de Cátion TRPV/análise , Canais de Cátion TRPV/antagonistas & inibidores , Canais de Cátion TRPV/fisiologia , Gânglio Trigeminal/química , Gânglio Trigeminal/efeitos dos fármacosRESUMO
OBJECTIVE: To test the hypothesis that the chemokine ligand 2/chemokine receptor 2 (CCL2/CCR2) signaling pathway plays an important role in pain induced by experimental tooth movement. MATERIALS AND METHODS: Expression of CCL2/CCR2 in the trigeminal ganglion (TG) was determined by Western blotting 0 hours, 4 hours, 1 day, 3 days, 5 days, and 7 days after tooth movement. CCL2 localization and cell size distribution were revealed by immunohistochemistry. The effects of increasing force on CCL2 expression and behavioral changes were investigated. Furthermore, the effects of CCL2/CCR2 antagonists on these changes in pain behaviors were all evaluated. Exogenous CCL2 was injected into periodontal tissues and cultured TG neurons with different concentrations, and then the pain responses or c-fos expression were assessed. RESULTS: Experimental tooth movement led to a statistically significant increase in CCL2/CCR2 expression from day 3 to day 7, especially in small to medium-sized TG neurons. It also triggered an increase in the time spent on directed face-grooming behaviors in a force magnitude-dependent and CCL2 dose-dependent manner. Pain induced by experimental tooth movement was effectively blocked by a CCR2 antagonist and by CCL2 neutralizing antibody. Also, exogenous CCL2 led to an increase in c-fos expression in cultured TG neurons, which was blocked by CCL2 neutralizing antibody. CONCLUSIONS: The peripheral CCL2/CCR2 axis is modulated by experimental tooth movement and involved in the development of tooth movement pain.
Assuntos
Quimiocina CCL2/análise , Citocinas/análise , Dor/metabolismo , Técnicas de Movimentação Dentária/instrumentação , Gânglio Trigeminal/química , Animais , Fenômenos Biomecânicos , Técnicas de Cultura de Células , Células Cultivadas , Quimiocina CCL2/antagonistas & inibidores , Quimiocina CCL2/fisiologia , Citocinas/fisiologia , Relação Dose-Resposta a Droga , Asseio Animal/efeitos dos fármacos , Masculino , Neurônios/química , Neurônios/efeitos dos fármacos , Nociceptividade/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-fos/análise , Ratos , Ratos Sprague-Dawley , Receptores CCR2/análise , Receptores CCR2/antagonistas & inibidores , Receptores CCR2/fisiologia , Transdução de Sinais/fisiologia , Estresse Mecânico , Fatores de Tempo , Gânglio Trigeminal/efeitos dos fármacosRESUMO
The aim of the study was to investigate the presence and distribution of the chromogranin A-derived peptide catestatin in the rat eye and trigeminal ganglion by immunofluorescence using an antibody which recognizes not only free catestatin but also larger fragments containing the sequence of catestatin. Western blots were performed in an attempt to characterize the immunoreactivities detected by the catestatin antiserum. Sparse immunoreactive nerve fibers were visualized in the corneal stroma, in the chamber angle, in the sphincter muscle but also in association with the dilator muscle, in the stroma of the ciliary body and processes, but dense in the irideal stroma, around blood vessels at the limbus and in the choroid and in cells of the innermost retina representing amacrine cells as identified by colocalization with substance P. Furthermore, catestatin-immunoreactivity was detected in the trigeminal ganglion in small to medium-sized cells and there were abundant catestatin-positive nerve fibers stained throughout the stroma of the ganglion. Double immunofluorescence of catestatin with substance P revealed colocalization both in cells of the trigeminal ganglion as well as in nerve fibers in the choroid. The immunoreactivities are present obviously as free catestatin and/or small-sized catestatin-containing fragments in the retina and ocular nerves but as large processed fragments as well, weak in the retina and more prominent in remaining ocular tissues, possibly in endothelial cells. This indicates that this peptide is a constituent of sensory neurons innervating the rat eye and the presence in amacrine cells in the retina is typical for neuropeptides. Catestatin is biologically highly active and might be of significance in the pathophysiology of the eye.
Assuntos
Cromogranina A/análise , Olho/química , Fragmentos de Peptídeos/análise , Animais , Cromogranina A/imunologia , Cromogranina A/metabolismo , Olho/anatomia & histologia , Olho/metabolismo , Imunofluorescência , Fragmentos de Peptídeos/imunologia , Fragmentos de Peptídeos/metabolismo , Ratos , Ratos Endogâmicos Lew , Substância P/metabolismo , Gânglio Trigeminal/química , Gânglio Trigeminal/metabolismoRESUMO
Gastrin-releasing peptide (GRP) has recently been identified as an itch-specific neuropeptide in the spinal sensory system in mice, but there are no reports of the expression and distribution of GRP in the trigeminal sensory system in mammals. We characterized and compared GRP-immunoreactive (ir) neurons in the trigeminal ganglion (TG) with those in the rat spinal dorsal root ganglion (DRG). GRP immunoreactivity was expressed in 12% of TG and 6% of DRG neurons and was restricted to the small- and medium-sized type cells. In both the TG and DRG, many GRP-ir neurons also expressed substance P and calcitonin gene-related peptide, but not isolectin B4 . The different proportions of GRP and transient receptor potential vanilloid 1 double-positive neurons in the TG and DRG imply that itch sensations via the TG and DRG pathways are transmitted through distinct mechanisms. The distribution of the axon terminals of GRP-ir primary afferents and their synaptic connectivity with the rat trigeminal sensory nuclei and spinal dorsal horn were investigated by using light and electron microscopic histochemistry. Although GRP-ir fibers were rarely observed in the trigeminal sensory nucleus principalis, oralis, and interpolaris, they were predominant in the superficial layers of the trigeminal sensory nucleus caudalis (Vc), similar to the spinal dorsal horn. Ultrastructural analysis revealed that GRP-ir terminals contained clear microvesicles and large dense-cored vesicles, and formed asymmetric synaptic contacts with a few dendrites in the Vc and spinal dorsal horn. These results suggest that GRP-dependent orofacial and spinal pruriceptive inputs are processed mainly in the superficial laminae of the Vc and spinal dorsal horn.
Assuntos
Gânglios Espinais/química , Peptídeo Liberador de Gastrina/análise , Células do Corno Posterior/química , Gânglio Trigeminal/química , Animais , Masculino , Ratos , Ratos WistarRESUMO
Nestin labels neuroepithelial stem cells and endothelial cells in newly formed blood vessels. The aim of the study was to investigate the immunolocalization of nestin in human adult trigeminal ganglia. Autopsy samples from eight human adult cadavers were paraffin embedded, and immunostained with anti-nestin antibody. Satellite glial cells (SGCs) and intraganglionic microvessels were positively labeled with nestin, which is usually expressed in endothelial cells of newly formed blood vessels. Nestin-positive SGCs have been previously reported in rat trigeminal ganglia. Our study is the first to identify them in human trigeminal ganglia. Further studies are needed to evaluate if the nestin phenotype of SGCs relates to the functional plasticity of these cells or to glial and/or neuronal remodeling in adults. Intrinsic angiogenesis in the adult trigeminal ganglion should be further checked as to whether it relates to a normal vascular remodeling or if it represents an overlooked determinant of trigeminal neuralgia.
Assuntos
Nestina/análise , Coloração e Rotulagem , Gânglio Trigeminal/química , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nestina/imunologia , Fenótipo , Gânglio Trigeminal/citologia , Gânglio Trigeminal/imunologiaRESUMO
The capacity of cutaneous, including trigeminal endings, to detect chemicals is known as chemesthesis or cutaneous chemosensation. This sensory function involves the activation of nociceptor and thermoreceptor endings and has a protective or defensive function, as many of these substances are irritants or poisonous. However, humans have also developed a liking for the distinct sharpness or pungency of many foods, beverages, and spices following activation of the same sensory afferents. Our understanding of the cellular and molecular mechanisms of chemosensation in the trigeminal system has experienced enormous progress in the past decade, following the cloning and functional characterization of several ion channels activated by physical and chemical stimuli. This brief review attempts to summarize our current knowledge in this field, including a functional description of various sensory channels, especially TRP channels, involved in trigeminal chemosensitivy. Finally, some of these new findings are discussed in the context of the pathophysiology of trigeminal chemosensation, including pain, pruritus, migraine, cough, airway inflammation, and ophthalmic diseases.
Assuntos
Células Quimiorreceptoras/fisiologia , Dor/fisiopatologia , Paladar/fisiologia , Tato/fisiologia , Nervo Trigêmeo/fisiologia , Animais , Células Quimiorreceptoras/química , Humanos , Canais de Cátion TRPV/fisiologia , Gânglio Trigeminal/química , Gânglio Trigeminal/fisiologia , Nervo Trigêmeo/químicaRESUMO
The terminal Schwann cells (TSCs) which play crucial roles in regeneration of the periodontal Ruffini endings (RE) exhibit immunoreaction for glial cell line-derived neurotrophic factor (GDNF). However, no information is available regarding the role of GDNF in the periodontal RE during nerve regeneration. This study was undertaken to examine the changes in GDNF expression in the rat periodontal RE following transection of the inferior alveolar nerve (IAN) using immunohistochemistry for GDNF and S-100 protein, a marker for the TSCs. We additionally investigated the changes in expression of GDNF in the trigeminal ganglion (TG) at protein and mRNA levels. A transection to IAN induced a disappearance of the TSCs from the alveolus-related part (ARP), followed by a migration of spindle-shaped cells with S-100 but without GDNF immunoreactions into the tooth-related part (TRP) by postoperative (PO) week 2. At PO week 2, GDNF immunoreacted cellular elements increased in number in the ARP although the spindle-shaped cells without GDNF reaction remained in the TRP. After PO week 4, many GDNF-positive TSCs appeared in the ARP though the spindle-shaped cells vanished from the TRP. A real time RT-PCR analysis demonstrated the highest elevation of GDNF mRNA in the TG at PO week 2. These findings suggested the involvement of this molecule in the maturation and maintenance of the periodontal RE during regeneration. Taken together with our previous and current studies, it appears that the regeneration of the periodontal RE is controlled by multiple neurotrophins in a stage-specific manner.
Assuntos
Fator Neurotrófico Derivado de Linhagem de Célula Glial/biossíntese , Incisivo/inervação , Mecanorreceptores/fisiologia , Regeneração Nervosa , Periodonto/inervação , Células de Schwann/metabolismo , Animais , Fator Neurotrófico Derivado de Linhagem de Célula Glial/genética , Imuno-Histoquímica , Nervo Mandibular/fisiologia , Ligamento Periodontal/inervação , RNA Mensageiro/genética , Ratos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteínas S100/genética , Proteínas S100/metabolismo , Gânglio Trigeminal/químicaRESUMO
Transient receptor potential channel-vanilloid subfamily member 1 (TRPV1) is an important target in the treatment of bladder overactivity. This receptor is suggested to function as a mechanosensor in the normal bladder and to mediate the development of bladder overactivity during cystitis. Our aim was to determine the cellular distribution of TRPV1 in mouse and rat bladder tissue. We used three different commercial TRPV1 antibodies to perform immunohistochemistry on bladder tissue from rats and wild-type and TRPV1(-/-) mice, using trigeminal ganglia as a control tissue for TRPV1 expression. Although two of the antibodies seemed to react specifically in trigeminal ganglion tissue, all the antibodies produced a similar staining pattern in the urothelium of wild-type and TRPV1(-/-) mice. These data show that TRPV1 antibodies can cause an aspecific immunostaining in bladder tissue, urging for additional research to confirm the exact distribution of TRPV1 in bladder. In conclusion, we think that the use of negative controls on knockout mice, whenever available, is mandatory when conducting immunohistochemical localization studies.
Assuntos
Anticorpos/imunologia , Especificidade de Anticorpos/imunologia , Canais de Cátion TRPV/análise , Canais de Cátion TRPV/imunologia , Bexiga Urinária/química , Animais , Feminino , Imuno-Histoquímica , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neurônios/química , Ratos , Ratos Wistar , Canais de Cátion TRPV/genética , Gânglio Trigeminal/química , Urotélio/químicaRESUMO
We tested the hypothesis that the 5HT(1D)R, the primary antinociceptive target of triptans, is differentially distributed in tissues responsible for migraine pain. The density of 5HT(1D)R was quantified in tissues obtained from adult female rats with Western blot analysis. Receptor location was assessed with immunohistochemistry. The density of 5HT(1D)R was significantly greater in tissues known to produce migraine-like pain (i.e. circle of Willis and dura) than in structures in which triptans have no antinociceptive efficacy (i.e. temporalis muscle). 5HT(1D)R-like immunoreactivity was restricted to neuronal fibres, where it colocalized with calcitonin gene-related peptide and tyrosine hydroxylase immunoreactive fibres. These results are consistent with our hypothesis that the limited therapeutic profile of triptans could reflect its differential peripheral distribution and that the antinociceptive efficacy reflects inhibition of neuropeptide release from sensory afferents. An additional site of action at sympathetic efferents is also suggested.